Akero Therapeutics (AKRO) is up 16.6%, or $7.74 to $54.23.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AKRO:
- Midday Fly By: Delta beats, PepsiCo names new CFO
- Akero downgraded to Market Perform from Outperform at LifeSci Capital
- Cautious Hold Rating on Akero Therapeutics Amid Novo Nordisk Acquisition and Regulatory Uncertainties
- Cautious Hold Rating on Akero Therapeutics Amid Acquisition Interest and Uncertainties in Efruxifermin’s Clinical Trajectory
- Akero Therapeutics downgraded to Hold from Buy at Jefferies